Home Fashion STEMTECH CORPORATION ANNOUNCES ANA GROENEWOLD ACHIEVES CHAIRMAN’S CLUB DIRECTOR STATUS

STEMTECH CORPORATION ANNOUNCES ANA GROENEWOLD ACHIEVES CHAIRMAN’S CLUB DIRECTOR STATUS


MIRAMAR, FL, June 09, 2022 (GLOBE NEWSWIRE) — Stemtech Company (“Stemtech”) (OTCQB:STEK), an revolutionary nutraceutical firm and a pioneer within the subject of ADVANCELLS stem cell diet, introduced at present that Ana Groenewold, an Impartial Enterprise Accomplice from Mexico, has attained the excessive rank of Chairman’s Membership Director in Might. This coincided with the GLD RSH 90-Day Promotion interval the place gross sales and recruitment reached a document 2022 Might.

“Ana is a really devoted and decided one that set her sights on changing into a Chairman’s Membership Director and excitedly attained this excessive rank in Might” says John W. Meyer, President & COO of Stemtech Company. “Stemtech is happy with Ana’s accomplishments and applauds her efforts to share the advantages of our nice merchandise and enterprise alternative” continued Meyer. “Chairman & CEO Charles Arnold and I each have been very glad to name Ana and congratulate her success”, mentioned Meyer. Ana Groenewold has labored with so many, together with Stemtech’s Managing Director of Latin Markets, Alejandro Carrillo, who expresses his admiration for Ana’s drive to succeed.

Ana commented that “I needed a undertaking with the potential to vary the world! 9 years in the past, I discovered Stemtech and since then the fervour was born in me to not cease for a single day! I like Stemtech, I like my life, I like my nice, nice crew!”

About Stemtech Company

Stemtech Company, a number one nutraceutical firm with a direct gross sales distribution mannequin, was based on April 18, 2018, after buying the operations from its predecessor Stemtech Worldwide, Inc. which was based in 2005. From 2010 by 2015, Stemtech Worldwide, Inc., was acknowledged 4 separate instances on the Inc. 5000 Quickest-Rising Corporations listing. In 2018, the Firm underwent an in depth government reorganization, and continued operations beneath new management. Stemtech makes a speciality of creating merchandise and formulation which might be patent protected within the U.S. and in choose worldwide markets. The Firm’s patented formulation assist the discharge, circulation and migration of the physique’s grownup stem cells from its bone marrow. The Firm markets its merchandise beneath the next manufacturers: RCM System, stemrelease3, Stemflo®, MigraStem®, OraStem® (Oral Well being Care), and D-Fuze(EMF Blocker). Its merchandise are all-natural and plant-based and manufactured beneath cGMP (Present Good Manufacturing Practices) beneath the auspices of the Dietary Complement Well being and Schooling Act (DSHEA). For extra info, please go to www.stemtech.com .

Ahead-Wanting Statements

This announcement incorporates forward-looking statements inside the that means of the “secure harbor” provisions of the U.S. Personal Securities Litigation Reform Act of 1995. Such statements embrace however aren’t restricted to statements recognized by phrases comparable to “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “targets,” “tasks” and comparable expressions. The statements on this launch are primarily based upon the present beliefs and expectations of our firm’s administration and are topic to important dangers and uncertainties. Precise outcomes might differ from these set forth within the forward-looking statements. Quite a few elements might trigger or contribute to such variations, together with, however not restricted to, outcomes of medical trials and/or different research, the challenges inherent in new product growth initiatives, the impact of any aggressive merchandise, our skill to license and shield our mental property, our skill to boost extra capital sooner or later that’s vital to take care of our enterprise, adjustments in authorities coverage and/or regulation, potential litigation by or in opposition to us, any governmental evaluate of our merchandise or practices, in addition to different dangers mentioned on occasion in our filings with the Securities and Trade Fee, together with, with out limitation, our newest 10-Okay filed April 1, 2022. We undertake no obligation to replace any forward-looking assertion, or any info contained on this press launch or in different public disclosures at any time. Lastly, the investing public is reminded that the one bulletins or details about Stemtech Company that are condoned by the Firm should emanate from the Firm itself and bear our identify as its Supply.

For Additional Info, Contact:

Traders: Frank J. Pena, 908-675-0581, fpena@stemtech.com

The content material is by GlobeNewswire. DKODING Media just isn’t answerable for the content material supplied or any hyperlinks associated to this content material. DKODING Media just isn’t answerable for the correctness, topicality or the standard of the content material.



Supply hyperlink

RELATED ARTICLES

Is Blue Garlic Protected to Eat?

With a couple of noticeable exceptions, corresponding to blueberries, blue raspberry sweet, and sure cocktails, blue will not be a coloration you need...

Cease Checking Your 401k So A lot

Photograph: Shutterstock (Shutterstock)Now greater than ever, heed this recommendation: Cease your 401k so rattling...

State Division Officers Meet With Griner’s WNBA Group

The State Division confirmed the assembly, which concerned officers from its specialised workplace that advocates for hostages and wrongfully detained Individuals, however supplied...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Too huge to jail: The story of HSBC and the Mexican drug cartel

In 2012, HSBC was fined $1.9bn and entered right into a Deferred Prosecution Settlement for facilitating the laundering of cash by the Mexican medication...

American Airways regional carriers hike pilot pay as scarcity persists

American Airways Embraer ERJ-145 regional jet plane as seen on closing strategy touchdown at New York JFK worldwide airport in NY, on February...

Recent Comments